| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 65.31% | -0.08% | -31.09% | 31/55 | 65.82% | 我武生物 | 95.37% | 行业排名> |
| 2025-06-30 | 94.77% | 21.99% | -0.5% | 3/55 | 67.7% | 我武生物 | 95.1% | 行业排名> |
| 2025-03-31 | 95.24% | 8.94% | 52.13% | 1/55 | 69.02% | 金迪克 | 95.24% | 行业排名> |
| 2024-12-31 | 62.61% | -19.54% | -4.22% | 36/55 | 68.55% | 我武生物 | 95.16% | 行业排名> |
| 2024-09-30 | 65.36% | -21.14% | -15.86% | 35/55 | 69.18% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 77.68% | -6.21% | -11.14% | 18/55 | 68.3% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 87.42% | 3.04% | 12.36% | 11/55 | 69.14% | 康华生物 | 96.08% | 行业排名> |
| 2023-12-31 | 77.81% | -7.5% | -6.12% | 22/55 | 68.02% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 82.88% | -2.76% | 0.07% | 17/55 | 68.07% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 82.83% | -6.86% | -2.37% | 17/55 | 63.32% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 84.84% | -4.98% | 0.86% | 18/55 | 69.48% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 84.12% | -1.53% | -1.31% | 19/55 | 68.17% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 85.24% | -4.39% | -4.15% | 19/55 | 71.28% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 88.93% | 4.25% | -0.41% | 11/55 | 69.18% | 我武生物 | 95.75% | 行业排名> |
| 2022-03-31 | 89.29% | 3.78% | 4.53% | 13/55 | 71.63% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-12-31 | 85.42% | -2.37% | -4.18% | 21/55 | 72.1% | 百奥泰 | 95.74% | 行业排名> |
| 2021-09-30 | 89.15% | 2% | 4.51% | 12/55 | 73.87% | 我武生物 | 95.89% | 行业排名> |
| 2021-06-30 | 85.31% | 1.26% | -0.85% | 20/55 | 73.72% | 百奥泰 | 96.33% | 行业排名> |
| 2021-03-31 | 86.04% | 2% | -1.66% | 15/55 | 73.03% | 义翘神州 | 96.83% | 行业排名> |
| 2020-12-31 | 87.49% | 3.7% | 3.85% | 15/55 | 71.61% | 义翘神州 | 96.88% | 行业排名> |
| 2020-06-30 | 84.25% | 2% | -0.15% | 23/55 | 88.2% | 义翘神州 | 96.56% | 行业排名> |
| 2019-12-31 | 84.37% | 2% | 2% | 22/55 | 72.44% | 华兰疫苗 | 707.43% | 行业排名> |

微信公众号
证券之星APP



